Washington H Soul Pattinson & Co. Ltd (ASX: SOL) is an investment house business which has been on the ASX for over a century. Its origins are in owning and operating Australian pharmacies, which is where the Soul Pattinson chemist chain comes from, however, that business is now owned by Australian Pharmaceutical Industries Ltd (ASX: API), which WHSP owns 19.3% of. WHSP invests in a large number of companies across a variety of industries such as construction, resources and telecommunications.
We pull apart the remaining ASX shares from last week, including Cochlear Limited (ASX: COH), Macquarie Group Ltd (ASX: MQG) and more.
All seven of these companies do something different. They have different prospects for growth. Different ways of generating dividends… and so on. When combined, they could make for a wicked cocktail of dividend income.
Sonic Healthcare Ltd (ASX: SHL) has traditionally viewed as an ASX share that provides a mixture of dividends and defensive growth for investors. However, SHL shares have been sold off 17% over the last 6 months.
Eight of the markets 11 sectors finished weaker, after retail sales grew at just 0.2 per cent in August, following an 0.5% increase in July. This is likely to ensure interest rates remain on hold. Consumer facing businesses Aristocrat Leisure Limited (ASX: ALL) and Wesfarmers Ltd (ASX: WES) fell 1.9% and 0.8%.
The Brickworks Limited (ASX:BKW) share price is down 7% after announcing a challenged FY23 result, though the dividend increased.
The Washington H. Soul Pattinson and Co. Ltd (ASX:SOL) (WHSP) share price is in focus after the investment stock announced its FY23 result.
Up 42%, is Washington H. Soul Pattinson & Co. Ltd (ASX: SOL) a growth stock? Maybe, but probably not.
May could be the perfect month to buy ASX growth shares. I think there are several that could deliver strong performance over the long-term.
May 2023 looks like a good month to consider investing in ASX dividend shares. Here are two to consider, including WHSP (ASX:SOL).
